370 related articles for article (PubMed ID: 30124196)
1. Systematic Review and Meta-analysis of Postexposure Prophylaxis for Crimean-Congo Hemorrhagic Fever Virus among Healthcare Workers.
Ergönül Ö; Keske Ş; Çeldir MG; Kara İA; Pshenichnaya N; Abuova G; Blumberg L; Gönen M
Emerg Infect Dis; 2018 Sep; 24(9):1642-1648. PubMed ID: 30124196
[TBL] [Abstract][Full Text] [Related]
2. Is ribavirin prophylaxis effective for nosocomial transmission of Crimean-Congo hemorrhagic fever?
Guner R; Hasanoglu I; Tasyaran MA; Yapar D; Keske S; Guven T; Yilmaz GR
Vector Borne Zoonotic Dis; 2014 Aug; 14(8):601-5. PubMed ID: 25072991
[TBL] [Abstract][Full Text] [Related]
3. A nosocomial transmission of crimean-congo hemorrhagic fever to an attending physician in North Kordufan, Sudan.
Elata AT; Karsany MS; Elageb RM; Hussain MA; Eltom KH; Elbashir MI; Aradaib IE
Virol J; 2011 Jun; 8():303. PubMed ID: 21672268
[TBL] [Abstract][Full Text] [Related]
4. [Crimean-Congo hemorrhagic fever: basics for general practitioners].
Flusin O; Iseni F; Rodrigues R; Paranhos-Baccalà G; Crance JM; Marianneau P; Bouloy M; Peyrefitte CN
Med Trop (Mars); 2010 Dec; 70(5-6):429-38. PubMed ID: 21520641
[TBL] [Abstract][Full Text] [Related]
5. Ribavirin Had Demonstrable Effects on the Crimean-Congo Hemorrhagic Fever Virus (CCHFV) Population and Load in a Patient With CCHF Infection.
Espy N; Pérez-Sautu U; Ramírez de Arellano E; Negredo A; Wiley MR; Bavari S; Díaz Menendez M; Sánchez-Seco MP; Palacios G
J Infect Dis; 2018 May; 217(12):1952-1956. PubMed ID: 29584885
[TBL] [Abstract][Full Text] [Related]
6. Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice.
Hawman DW; Haddock E; Meade-White K; Williamson B; Hanley PW; Rosenke K; Komeno T; Furuta Y; Gowen BB; Feldmann H
Antiviral Res; 2018 Sep; 157():18-26. PubMed ID: 29936152
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran.
Mardani M; Jahromi MK; Naieni KH; Zeinali M
Clin Infect Dis; 2003 Jun; 36(12):1613-8. PubMed ID: 12802764
[TBL] [Abstract][Full Text] [Related]
8. Effect of oral ribavirin treatment on the viral load and disease progression in Crimean-Congo hemorrhagic fever.
Bodur H; Erbay A; Akıncı E; Öngürü P; Bayazıt N; Eren SS; Kubar A
Int J Infect Dis; 2011 Jan; 15(1):e44-7. PubMed ID: 21106428
[TBL] [Abstract][Full Text] [Related]
9. Crimean-Congo hemorrhagic fever.
Vorou R; Pierroutsakos IN; Maltezou HC
Curr Opin Infect Dis; 2007 Oct; 20(5):495-500. PubMed ID: 17762783
[TBL] [Abstract][Full Text] [Related]
10. Short report: Crimean-Congo hemorrhagic fever outbreak in Rawalpindi, Pakistan, February 2002.
Athar MN; Baqai HZ; Ahmad M; Khalid MA; Bashir N; Ahmad AM; Balouch AH; Bashir K
Am J Trop Med Hyg; 2003 Sep; 69(3):284-7. PubMed ID: 14628945
[TBL] [Abstract][Full Text] [Related]
11. Molecular (ticks) and serological (humans) study of Crimean-Congo hemorrhagic fever virus in the Iberian Peninsula, 2013-2015.
Palomar AM; Portillo A; Santibáñez S; García-Álvarez L; Muñoz-Sanz A; Márquez FJ; Romero L; Eiros JM; Oteo JA
Enferm Infecc Microbiol Clin; 2017; 35(6):344-347. PubMed ID: 28291670
[TBL] [Abstract][Full Text] [Related]
12. An Unexpected Fatal CCHF Case and Management of Exposed Health Care Workers.
Guven G; Talan L; Altintas ND; Memikoglu KO; Yoruk F; Azap A
Int J Infect Dis; 2017 Feb; 55():118-121. PubMed ID: 28069471
[TBL] [Abstract][Full Text] [Related]
13. Investigating the effect of ribavirin treatment on genetic mutations in Crimean-Congo haemorrhagic fever virus (CCHFV) through next-generation sequencing.
D'Addiego J; Elaldi N; Wand N; Osman K; Bagci BK; Kennedy E; Pektas AN; Hart E; Slack G; Hewson R
J Med Virol; 2023 Feb; 95(2):e28548. PubMed ID: 36734067
[TBL] [Abstract][Full Text] [Related]
14. [Crimean-Congo hemorrhagic fever : an emerging viral hemorrhagic fever in Europe].
Stavropoulou E; Troillet N
Rev Med Suisse; 2018 Oct; 14(622):1786-1789. PubMed ID: 30307137
[TBL] [Abstract][Full Text] [Related]
15. Ribavirin is not effective against Crimean-Congo hemorrhagic fever: observations from the Turkish experience.
Ceylan B; Calıca A; Ak O; Akkoyunlu Y; Turhan V
Int J Infect Dis; 2013 Oct; 17(10):e799-801. PubMed ID: 23773242
[TBL] [Abstract][Full Text] [Related]
16. New aspects about Crimean-Congo hemorrhagic fever (CCHF) cases and associated fatality trends: A global systematic review and meta-analysis.
Nasirian H
Comp Immunol Microbiol Infect Dis; 2020 Apr; 69():101429. PubMed ID: 32062190
[TBL] [Abstract][Full Text] [Related]
17. Crimean-Congo hemorrhagic fever among health care workers, Turkey.
Celikbas AK; Dokuzoğuz B; Baykam N; Gok SE; Eroğlu MN; Midilli K; Zeller H; Ergonul O
Emerg Infect Dis; 2014 Mar; 20(3):477-9. PubMed ID: 24564994
[TBL] [Abstract][Full Text] [Related]
18. The outcome of patients with Crimean-Congo hemorrhagic fever in Zahedan, southeast of Iran: a comparative study.
Sharifi-Mood B; Metanat M; Ghorbani-Vaghei A; Fayyaz-Jahani F; Akrami E
Arch Iran Med; 2009 Mar; 12(2):151-3. PubMed ID: 19249885
[TBL] [Abstract][Full Text] [Related]
19. Crimean Congo hemorrhagic fever: requires vigilance and not panic.
Bajpai S; Nadkar MY
J Assoc Physicians India; 2011 Mar; 59():164-7. PubMed ID: 21751625
[TBL] [Abstract][Full Text] [Related]
20. Crimean Congo hemorrhagic fever serosurvey in humans for identifying high-risk populations and high-risk areas in the endemic state of Gujarat, India.
Mourya DT; Yadav PD; Gurav YK; Pardeshi PG; Shete AM; Jain R; Raval DD; Upadhyay KJ; Patil DY
BMC Infect Dis; 2019 Feb; 19(1):104. PubMed ID: 30709372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
